A Clinical Study of Islatravir and Its Interaction With Lamivudine (MK-8591-058)
Status:
COMPLETED
Trial end date:
2024-07-14
Target enrollment:
Participant gender:
Summary
The goal of this study is to learn what happens to the medication islatravir (ISL), in a healthy person's body over time--called a pharmacokinetic (PK) study. Researchers want to compare the amount of islatravir in the blood when it is taken alone as a single dose and when it is taken with multiple doses of another medication called lamivudine (3TC).